SEC Form 4 · accession 0001179110-16-017003
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Georges Gemayel
Director
Period of report
Jan 1, 2016
Accepted (ET)
Jan 5, 2016 · 1:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $14.84 | Jan 1, 2016 | A | 30,000 | A | Jan 1, 2019 | Jan 1, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Represents options granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria such options vest with 10,000 shares of such option one year following the date of grant and 20,000 shares of such option to vest thereafter in equal quarterly installments over the next two year period.